Jubilant Pharmova Limited
JUBLPHARMA
Quarterly results
Revenue and net profit
₹ crore
Drag across a chart to read any period; every figure is listed under it. Tap the name of a metric for its year-on-year change.
- Income
- ₹ crore
Jun 202667
Quarter ₹ crore YoY Jun 2024 167 -23.3% Sept 2024 166 -11.1% Dec 2024 196 +11.9% Mar 2025 217 +5.6% Jun 2025 60 -64.3% Sept 2025 66 -59.9% Dec 2025 67 -65.7% Mar 2026 70 -67.6% Jun 2026 67 +12.8% - ₹ crore
Jun 20260.10
Quarter ₹ crore Jun 2024 20 Sept 2024 44 Dec 2024 18 Mar 2025 18 Jun 2025 0.70 Sept 2025 0.80 Dec 2025 0.40 Mar 2026 0.50 Jun 2026 0.10 - ₹ crore
Jun 202667
Quarter ₹ crore Jun 2024 186 Sept 2024 210 Dec 2024 214 Mar 2025 235 Jun 2025 60 Sept 2025 67 Dec 2025 68 Mar 2026 71 Jun 2026 67 - Cost structure
- ₹ crore
Jun 202628
Quarter ₹ crore Jun 2024 49 Sept 2024 51 Dec 2024 52 Mar 2025 51 Jun 2025 23 Sept 2025 27 Dec 2025 29 Mar 2026 25 Jun 2026 28 - ₹ crore
Jun 202657
Quarter ₹ crore Jun 2024 186 Sept 2024 193 Dec 2024 206 Mar 2025 212 Jun 2025 54 Sept 2025 59 Dec 2025 58 Mar 2026 58 Jun 2026 57 - Exceptional items and tax
- ₹ crore
Jun 202610
Quarter ₹ crore Jun 2024 -11 Sept 2024 17 Dec 2024 9 Mar 2025 24 Jun 2025 7 Sept 2025 9 Dec 2025 10 Mar 2026 4 Jun 2026 10 - ₹ crore
Jun 20263
Quarter ₹ crore Jun 2024 -1 Sept 2024 6 Dec 2024 3 Mar 2025 10 Jun 2025 2 Sept 2025 57 Dec 2025 4 Mar 2026 -53 Jun 2026 3 - Profit
- ₹ crore
Jun 20267
Quarter ₹ crore YoY Jun 2024 -10 -636.8% Sept 2024 11 +2725.0%* Dec 2024 5 +320.8%* Mar 2025 14 -58.2% Jun 2025 6 +156.9%* Sept 2025 -6 -161.0% Dec 2025 7 +24.5% Mar 2026 57 +320.6% Jun 2026 7 +25.9% - Per share
- ₹ per share
Jun 20260.46
Quarter ₹ per share Jun 2024 -0.64 Sept 2024 0.66 Dec 2024 0.33 Mar 2025 0.86 Jun 2025 0.36 Sept 2025 -0.40 Dec 2025 0.42 Mar 2026 3.59 Jun 2026 0.46 - Leverage
Debt to equity
timesDec 20240.00x
Quarter times Jun 2024 — Sept 2024 0.00x Dec 2024 0.00x Mar 2025 — Jun 2025 — Sept 2025 — Dec 2025 — Mar 2026 — Jun 2026 —
| ₹ crore | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|
| Income | |||||||||
| 167 | 166 | 196 | 217 | 60 | 66 | 67 | 70 | 67 | |
| Revenue YoY | -23.3% | -11.1% | +11.9% | +5.6% | -64.3% | -59.9% | -65.7% | -67.6% | +12.8% |
| 20 | 44 | 18 | 18 | 0.70 | 0.80 | 0.40 | 0.50 | 0.10 | |
| 186 | 210 | 214 | 235 | 60 | 67 | 68 | 71 | 67 | |
| Cost structure | |||||||||
| 49 | 51 | 52 | 51 | 23 | 27 | 29 | 25 | 28 | |
| 186 | 193 | 206 | 212 | 54 | 59 | 58 | 58 | 57 | |
| Exceptional items and tax | |||||||||
| -11 | 17 | 9 | 24 | 7 | 9 | 10 | 4 | 10 | |
| -1 | 6 | 3 | 10 | 2 | 57 | 4 | -53 | 3 | |
| Profit | |||||||||
| -10 | 11 | 5 | 14 | 6 | -6 | 7 | 57 | 7 | |
| Net profit YoY | -636.8% | +2725.0%* | +320.8%* | -58.2% | +156.9%* | -161.0% | +24.5% | +320.6% | +25.9% |
| Per share | |||||||||
| -0.64 | 0.66 | 0.33 | 0.86 | 0.36 | -0.40 | 0.42 | 3.59 | 0.46 | |
| Leverage | |||||||||
| Debt to equity | — | 0.00x | 0.00x | — | — | — | — | — | — |
Latest filed period ends Jun 2026. Figures are in ₹ crore except rows named with a %, which are percentages, and EPS, which is rupees per share. An asterisk on a YoY figure means the prior period was a loss, so the percentage is computed on its absolute value. Click an underlined row name for its year-on-year change, against the same period a year earlier — blank where that period was not filed, or, on rows other than revenue and net profit, where it is not one of the 9 shown. Every blank change says which of the two it is when you rest on the dash, so a gap in the oldest columns need not be read as no growth. Rows that are already a ratio carry no change: a move from 2.00% to 2.24% is 24 basis points, not a percentage.